Characteristic submucosal alteration in biliary carcinogenesis of pancreaticobiliary maljunction with a focus on inflammasome activation
- PMID: 36259178
- DOI: 10.1002/jhbp.1253
Characteristic submucosal alteration in biliary carcinogenesis of pancreaticobiliary maljunction with a focus on inflammasome activation
Abstract
Background: This study investigated submucosal alterations in biliary carcinogenesis of pancreaticobiliary maljunction (PBM).
Methods: Thirty-three patients with PBM (including seven with gallbladder [GB] cancer), four with neither biliary tract cancer nor PBM who underwent pancreaticoduodenectomy (controls), and seven with chronic cholecystitis without PBM were enrolled. Protein expression of α-smooth muscle actin (αSMA), CD68, and CD204 in the GB lamina propria and that of NLRP3 and caspase 1 in the GB epithelium and lamina propria were examined.
Results: Compared with the control and cholecystitis groups, αSMA expression was higher in the cancerous part (stroma) of the GB in patients with GB cancer + PBM and in the lamina propria of patients with PBM. The CD204/CD68 ratio in the lamina propria was higher in the PBM group than in the control and cholecystitis groups. NLRP3 and caspase 1 expression in both the lamina propria and epithelium was higher in the PBM than control group. In the PBM group, NLRP3- and caspase 1-positive cells in the lamina propria were located near the epithelium.
Conclusion: Activated fibroblasts and M2 macrophages in the GB lamina propria may be associated with biliary carcinogenesis of PBM, possibly through inflammasome activation.
Keywords: M2 macrophage; NLRP3; activated fibroblast; biliary cancer; caspase 1.
© 2022 Japanese Society of Hepato-Biliary-Pancreatic Surgery.
Similar articles
-
Biliary carcinogenesis in pancreaticobiliary maljunction.J Gastroenterol. 2017 Feb;52(2):158-163. doi: 10.1007/s00535-016-1268-z. Epub 2016 Oct 4. J Gastroenterol. 2017. PMID: 27704265 Review.
-
Pancreaticobiliary maljunction and carcinogenesis to biliary and pancreatic malignancy.Langenbecks Arch Surg. 2009 Jan;394(1):159-69. doi: 10.1007/s00423-008-0336-0. Epub 2008 May 24. Langenbecks Arch Surg. 2009. PMID: 18500533 Review.
-
Clinical and genetic analysis of noncancerous and cancerous biliary epithelium in patients with pancreaticobiliary maljunction.World J Surg. 2002 Jan;26(1):91-8. doi: 10.1007/s00268-001-0187-0. Epub 2001 Nov 26. World J Surg. 2002. PMID: 11898040
-
Pancreaticobiliary maljunction and biliary cancer.J Gastroenterol. 2015 Mar;50(3):273-9. doi: 10.1007/s00535-014-1015-2. Epub 2014 Nov 18. J Gastroenterol. 2015. PMID: 25404143 Review.
-
K-ras point mutations in cancerous and noncancerous biliary epithelium in patients with pancreaticobiliary maljunction.Cancer. 1996 Apr 15;77(8 Suppl):1752-7. doi: 10.1002/(SICI)1097-0142(19960415)77:8<1752::AID-CNCR51>3.0.CO;2-V. Cancer. 1996. PMID: 8608574
Cited by
-
Diversity and heterogeneity in human pancreaticobiliary maljunction revealed by single-cell RNA sequencing.Pediatr Surg Int. 2025 Mar 21;41(1):98. doi: 10.1007/s00383-025-05997-w. Pediatr Surg Int. 2025. PMID: 40116982
References
REFERENCES
-
- Morine Y, Shimada M, Takamatsu H, Araida T, Endo I, Kubota M, et al. Clinical features of pancreaticobiliary maljunction: update analysis of 2nd Japan-nationwide survey. J Hepatobiliary Pancreat Sci. 2013;20(5):472-80.
-
- Matsubara T, Sakurai Y, Zhi LZ, Miura H, Ochiai M, Funabiki T. K-ras and p53 gene mutations in noncancerous biliary lesions of patients with pancreaticobiliary maljunction. J Hepatobiliary Pancreat Surg. 2002;9(3):312-21.
-
- Tokuda K, Morine Y, Miyazaki K, Yamada S, Saito Y, Nishi M, et al. The interaction between cancer associated fibroblasts and tumor associated macrophages via the osteopontin pathway in the tumor microenvironment of hepatocellular carcinoma. Oncotarget. 2021;12(4):333-43.
-
- Chen S, Morine Y, Tokuda K, Yamada S, Saito Y, Nishi M, et al. Cancer-associated fibroblast-induced M2-polarized macrophages promote hepatocellular carcinoma progression via the plasminogen activator inhibitor-1 pathway. Int J Oncol. 2021;59(2):59.
-
- Hashimoto O, Yoshida M, Koma Y, Yanai T, Hasegawa D, Kosaka Y, et al. Collaboration of cancer-associated fibroblasts and tumour-associated macrophages for neuroblastoma development. J Pathol. 2016;240(2):211-23.
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical